Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Study on Reducing Chronic Migraine Days with CGRP Antibodies and Botulinum Toxin A in Adults Aged 18-70
FinlandStudy on the Safety and Effects of ORX750 for Patients with Narcolepsy and Idiopathic Hypersomnia
FranceStudy of ENTR-601-45 Safety and Effectiveness in Patients with Duchenne Muscular Dystrophy Who Can Skip Exon 45
BelgiumStudy on ITI-1284 for Treating Psychosis in Alzheimer's Patients
BulgariaStudy of Light Therapy and Melatonin for Treatment of Major Depressive Episode with Insomnia
FranceStudy of cilostazol and nimodipine combination to improve outcomes in patients with aneurysmal subarachnoid hemorrhage
FranceStudy of clopidogrel and acetylsalicylic acid (aspirin) for prevention of cardiovascular events in patients who survived intracerebral hemorrhage stroke
BelgiumStudy of TAK-360 tablets to evaluate safety and effectiveness in people with Idiopathic Hypersomnia
FranceStudy of levetiracetam to prevent seizures in adults who have both Down syndrome and Alzheimer's disease
SpainStudy on Amlodipine for Treating Reversible Cerebral Vasoconstriction Syndrome in Patients Without Brain Lesions or Hemorrhage
FinlandStudy on Long-term Safety and Efficacy of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
BelgiumLong-Term Study on the Safety and Effects of ALKS 2680 for Patients with Narcolepsy Type 1 and Type 2
BelgiumThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
